Literature DB >> 16973808

Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease.

R Sharma, D C Gaze, D Pellerin, R L Mehta, H Gregson, C P Streather, P O Collinson, S J D Brecker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16973808      PMCID： PMC1861028          DOI： 10.1136/hrt.2005.082313

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

Authors:  James L Januzzi; Carlos A Camargo; Saif Anwaruddin; Aaron L Baggish; Annabel A Chen; Daniel G Krauser; Roderick Tung; Renee Cameron; J Tobias Nagurney; Claudia U Chae; Donald M Lloyd-Jones; David F Brown; Stacy Foran-Melanson; Patrick M Sluss; Elizabeth Lee-Lewandrowski; Kent B Lewandrowski
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

2.  Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates.

Authors:  R Sharma; D Pellerin; D C Gaze; J S Shah; C P Streather; P O Collinson; S J Brecker
Journal:  Eur J Echocardiogr       Date:  2005-10

3.  N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.

Authors:  Christopher R DeFilippi; Jeffrey C Fink; Caitlin M Nass; Hegang Chen; Robert Christenson
Journal:  Am J Kidney Dis       Date:  2005-07       Impact factor: 8.860

4.  Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.

Authors:  Ian Loke; Iain B Squire; Joan E Davies; Leong L Ng
Journal:  Eur J Heart Fail       Date:  2003-10       Impact factor: 15.534

5.  Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.

Authors:  Fred S Apple; Maryann M Murakami; Lesly A Pearce; Charles A Herzog
Journal:  Clin Chem       Date:  2004-09-13       Impact factor: 8.327
  5 in total
  5 in total

1.  Association between N-terminal pro-brain natriuretic peptide and acute ischemic stroke in patients on chronic hemodialysis.

Authors:  Yong Kyun Kim; Seok Joon Shin; Sang-Hyun Ihm; Chan Seok Park; Hee-Yeol Kim; Young-Du Kim; Dong Suk Shim; Ho Cheol Song; Chul Woo Yang; Yong-Soo Kim; Euy Jin Choi
Journal:  Int Urol Nephrol       Date:  2009-12-29       Impact factor: 2.370

Review 2.  Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?

Authors:  Thanat Chaikijurajai; Hernan Rincon Choles; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-09-17

3.  Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients.

Authors:  Chih-Hsien Wang; Jen-Pi Tsai; Yu-Hsien Lai; Yu-Li Lin; Chiu-Huang Kuo; Bang-Gee Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2016-05-28

4.  B-type natriuretic peptide and prognosis of end-stage renal disease: a meta-analysis.

Authors:  Yun-Jiu Cheng; Feng-Juan Yao; Li-Juan Liu; Kai Tang; Xiao-Xiong Lin; Wei-Jie Li; Jing Zhang; Su-Hua Wu
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

5.  Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease.

Authors:  Julio Perez-Downes; Carlos Palacio; Saif Ibrahim; Patrisha Shelley; Alan Miller; Pramod Reddy
Journal:  J Geriatr Cardiol       Date:  2018-07       Impact factor: 3.327
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.